Search clinical trials for: Oral Tumors
Total 32695 results
-
Cyteir Therapeutics, Inc.Active, not recruitingSoft Tissue Sarcoma | Follicular Lymphoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Multiple Myeloma | Pancreatic Cancer | Ovarian Cancer | Mantle Cell Lymphoma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | DLBCL | Non-hodgkin Lymphoma | Malignancy | CLLUnited States
-
Eisai Inc.Completed
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
Athenex, Inc.Merck Sharp & Dohme LLCTerminated
-
SK Life Science, Inc.Completed
-
Jie He, MDCompleted
-
Roswell Park Cancer InstituteCompleted
-
Affiliated Cancer Hospital & Institute of Guangzhou...Completed
-
Beijing Friendship HospitalCompleted
-
Shanghai Henlius BiotechCompleted
-
Pierre Fabre MedicamentBiotrialCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
Rigshospitalet, DenmarkCompleted
-
Center Trials & TreatmentBioGene PharmaceuticalWithdrawnBreast Neoplasm | Advanced or Recurrent Solid TumorsAlbania
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid NeoplasmUnited States
-
Maastricht Radiation OncologyActive, not recruiting
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Peking UniversityThe First Affiliated Hospital with Nanjing Medical University; Xiangya Hospital... and other collaboratorsActive, not recruitingGastrointestinal Stromal TumorsChina
-
CelgeneCompletedDiffuse Large B-Cell Lymphoma | Multiple Myeloma | Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Glioblastoma Multiforme | Neuroendocrine Tumors of Non-Pancreatic Origin | Hormone Receptor-Positive Breast CancerUnited States, Spain, United Kingdom, France
-
Basilea PharmaceuticaCompletedNeoplasmsBelgium, United Kingdom, Germany, Switzerland
-
Deciphera Pharmaceuticals LLCCompletedGastrointestinal Stromal TumorsUnited States, France, Finland, United Kingdom, Germany, Netherlands, Italy, Belgium, Spain, Canada, Australia, Poland, Singapore
-
Biosplice Therapeutics, Inc.Active, not recruitingColorectal Cancer | Non-small Cell Lung Cancer | Castration-resistant Prostate CancerUnited States, Australia
-
Biosplice Therapeutics, Inc.Active, not recruitingSolid Tumor, AdultUnited States
-
Black Diamond Therapeutics, Inc.TerminatedSolid TumorUnited States, Denmark, France, Spain
-
Oblato, Inc.WithdrawnGlioblastoma | Astrocytoma | Oligodendroglioma
-
Chang Gung Memorial HospitalCompletedUrinary Bladder, Overactive | Sexual Behavior | Sexual Function Disturbances | Behavior Therapy | Sexual ActivityTaiwan
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Shanghai Antengene Corporation LimitedTerminatedAdvanced Solid TumorsChina
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Roswell Park Cancer InstituteCompletedRecurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the... and other conditionsUnited States
-
Epitopoietic Research CorporationUniversity of California, IrvineActive, not recruitingGlioblastoma | GliosarcomaUnited States
-
Kadmon Corporation, LLCCompleted
-
Kadmon Corporation, LLCCompleted
-
Sheba Medical CenterCompletedUlcerative ColitisIsrael, China, France, Greece, Italy, Korea, Republic of, Serbia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedMalignant Glioma | Recurrent GlioblastomaUnited States
-
South Plains Oncology ConsortiumThe Evan FoundationTerminatedNeuroblastoma | Recurrent NeuroblastomaUnited States
-
South Plains Oncology ConsortiumNo longer availableNeuroblastoma | Recurrent NeuroblastomaUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMalignant GliomaUnited States
-
Yeouido St. Mary's HospitalSamsung Medical Center; Seoul National University Bundang HospitalCompletedType 2 Diabetes | Osteoporosis, PostmenopausalKorea, Republic of
-
University of UtahCompletedMelanoma (Skin)United States
-
University of UtahCompletedMelanoma (Skin)United States
-
University of Colorado, DenverUniversity of KentuckyCompletedRefractory Solid Tumors | Relapsed Solid TumorsUnited States
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic GliomasUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsNetherlands, Spain, United Kingdom, United States, Belgium
-
National Cancer Institute (NCI)Completed
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
University of Texas Southwestern Medical CenterBayerWithdrawn